Important Regulatory Update: On March 31, 2025, the U.S. District Court for the Eastern District of Texas vacated the FDA’s Final Rule concerning Laboratory Developed Tests (LDTs). This decision effectively removes FDA-imposed restrictions and reaffirms the oversight of LDTs under CLIA regulations managed by CMS. What does this mean for your lab? Continuing Use […]
